A comparative efficacy trial in Germany in which infants received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) vaccine or DT vaccine.

Developments in biological standardization

Volumn 89, Issue , 1997, Pages 58-62

  Stehr, K ^a   Cherry, J D ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS VACCINE; DIPHTHERIA TOXOID; TETANUS TOXOID; VACCINE;

ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; GERMANY; HUMAN; INFANT; PERTUSSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

CLINICAL PROTOCOLS; COHORT STUDIES; DIPHTHERIA TOXOID; DIPHTHERIA-TETANUS VACCINE; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DOUBLE-BLIND METHOD; GERMANY; HUMANS; INFANT; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; TETANUS TOXOID; VACCINES, COMBINED; WHOOPING COUGH;

EID: 0030630058     PISSN: 03015149     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)